Quick Answer
PURPLE BIOTECH LTD. reported Total Assets of $17.57 million for fiscal year 2025.
PURPLE BIOTECH LTD. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $17.57M -52.6% |
$37.04M -16.4% |
$44.30M -18.9% |
$54.62M -22.2% |
$70.20M -16.2% |
$83.80M +469.4% |
| R&D Expense | $3.73M -51.0% |
$7.62M -55.3% |
$17.03M +4.4% |
$16.32M +38.0% |
$11.83M +63.4% |
$7.24M +217.7% |
- PURPLE BIOTECH LTD. reported Total Assets of $17.57 million for fiscal year 2025.
- PURPLE BIOTECH LTD. showed a decrease of -52.6% in Total Assets compared to the prior fiscal year.
- PURPLE BIOTECH LTD. reported R&D Expense of $3.73 million for fiscal year 2025.
- PURPLE BIOTECH LTD. showed a decrease of -51.0% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: